Asset
Monalizumab
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02331875 | phase1_2 | terminated | 2014-12-01 | 2016-12-01 | Innate Pharma | Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral Cavity |
FDA applications (0)
This company has no applications containing this asset.